RE:RE:ASCOThanks Westcoast. Although an increase in survival would certainly validate pela's advocacy I am not certain it would provide the desired effect on the sp. Already they have shown impressive survival numbers and it has done very little to propel the share price. Geneman, who I followed on the V2 board years ago, suggested more information on turning cold tumors hot might do it. Of course announcing a partner or AA would certainly provide that sudden sp appreciation. Perhaps ASCO will be the stimulus for one of these events.